Patent · US Expired

Immunotherapeutic agents

US6518281B2 · kind B2 · utility

10Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2001
Grant dateFeb 11, 2003
Priority date—
Expiry dateJul 20, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D209/46
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Novel amides and imides are inhibitors of tumor necrosis factor&agr; and phosphodiesterase and can be used to combat cachexia, endotoxic shock, retrovirus replication, asthma, and inflammatory conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.